Immunohistochemical (IHC) assay involves applying three specific monoclonal antibodies against three different protein antigens (markers) to a single tissue slide. It is used to confirm a diagnosis, subclassify a tumor, or simultaneously evaluate a small group of related therapeutic and prognostic indicators.